900120 — CXI Healthcare Technology Balance Sheet
0.000.00%
- KR₩16bn
- -KR₩202bn
- CNY297.02m
- 34
- 100
- 18
- 50
Annual balance sheet for CXI Healthcare Technology, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 148 | 341 | 522 | 840 | 1,060 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 206 | 174 | 145 | 142 | 97.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 362 | 518 | 670 | 983 | 1,158 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,783 | 1,650 | 1,522 | 1,373 | 1,250 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,201 | 2,220 | 2,298 | 2,541 | 2,612 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 72.4 | 45.3 | 15.4 | 13.5 | 10.5 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 72.8 | 45.9 | 18.6 | 14.3 | 13.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 2,128 | 2,174 | 2,279 | 2,527 | 2,599 |
| Total Liabilities & Shareholders' Equity | 2,201 | 2,220 | 2,298 | 2,541 | 2,612 |
| Total Common Shares Outstanding |